LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

2.21 -1.78

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.15

Максимум

2.27

Ключови измерители
By Trading Economics
Служители	26

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+1008.49% upside

Дивиденти
By Dow Jones
Следващи печалби	11.11.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-5.1M 15M
Предишно отваряне	3.99
Предишно затваряне	2.21

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.09.2025 г., 23:01 ч. UTC

Придобивния, сливания и поглъщания

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid -- Update

17.09.2025 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid

17.09.2025 г., 21:59 ч. UTC

Печалби

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

17.09.2025 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise as Yen Weakens -- Market Talk

17.09.2025 г., 23:39 ч. UTC

Пазарно говорене

Gold Rises Amid Prospects of Further Fed Rate Cuts -- Market Talk

17.09.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Santos: XRG Consortium Wouldn't Agree to Appropriate Risk Allocation Between It and Santos Shareholders

17.09.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Santos: XRG Consortium Wouldn't Agree to Acceptable Terms That Protected Value of Transaction

17.09.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Santos Had Expressed Concern to XRG Consortium About Delays in Agreeing to Scheme Implementation Agreement

17.09.2025 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Santos: Consortium Notified Board of Decision to Withdraw Proposal on Weds Evening

17.09.2025 г., 22:18 ч. UTC

Придобивния, сливания и поглъщания

Santos Confirms XRG Consortium Has Withdrawn Takeover Proposal

17.09.2025 г., 21:00 ч. UTC

Печалби

Darden Restaurants to Report Earnings. Why the Olive Garden Parent Is Expected to Stay Strong. -- Barrons.com

17.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

17.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.09.2025 г., 19:59 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.09.2025 г., 19:59 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Rise as Fed Cuts, Powell Warns of Risks -- Market Talk

17.09.2025 г., 19:07 ч. UTC

Пазарно говорене

Oil Futures Snap Three-Session Winning Streak -- Market Talk

17.09.2025 г., 18:43 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Reverse Course as Powell Talks to Reporters -- Market Talk

17.09.2025 г., 18:38 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Mixed Ahead of Storage Data -- Market Talk

17.09.2025 г., 18:20 ч. UTC

Пазарно говорене

Gold Dips After Quarter-Point Rate Cut -- Market Talk

17.09.2025 г., 18:18 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.09.2025 г., 18:18 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Fall on Nearly Unanimous Fed Cut -- Market Talk

17.09.2025 г., 18:14 ч. UTC

Пазарно говорене

Oil Slips Some More as Fed Makes Expected 25 Bp Rate Cut -- Market Talk

17.09.2025 г., 17:59 ч. UTC

Пазарно говорене

Soyoil Takes Hit as Traders Consider EPA Proposal -- Market Talk

17.09.2025 г., 17:15 ч. UTC

Придобивния, сливания и поглъщания

Netflix 'Has Won The Streaming Wars,' Analyst Says. The Stock Is a Buy. -- Barrons.com

17.09.2025 г., 17:06 ч. UTC

Придобивния, сливания и поглъщания

Walmart Stock Heads for a Record High. The Retailer Could Become a Leader in 'Agentic' AI. -- Barrons.com

17.09.2025 г., 16:51 ч. UTC

Печалби

Correct: Exor 1H Net Loss -EUR624M

17.09.2025 г., 16:34 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.09.2025 г., 16:34 ч. UTC

Пазарно говорене

Bank of Canada Ditches Resilience Talk, Plays Up Slowing Growth -- Market Talk

17.09.2025 г., 16:25 ч. UTC

Печалби

Wolters Kluwer: July, August Saw a Slight Increase in Organic Growth Compared to 1H

17.09.2025 г., 16:23 ч. UTC

Печалби

Wolters Kluwer: Year-to-Date Performance In Line With 2025 Guidance

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Ценова цел

By TipRanks

1008.49% нагоре

12-месечна прогноза

Среден 23.5 USD 1008.49%

Висок 32 USD

Нисък 15 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Lisata Therapeutics през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.